Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
362 | 3 | SNAKE VENOM//TOXICON//PHOSPHOLIPASE A2 | 35813 |
929 | 2 | LEUKOTRIENES//5 LIPOXYGENASE//EXPT THER EUT REPERFUS INJURY | 11261 |
18928 | 1 | 12S HETE//LY293111//12 LIPOXYGENASE | 553 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | 12S HETE | authKW | 486311 | 3% | 53% | 16 |
2 | LY293111 | authKW | 279253 | 1% | 70% | 7 |
3 | 12 LIPOXYGENASE | authKW | 208259 | 5% | 15% | 25 |
4 | BIOMIDE S | address | 170974 | 1% | 100% | 3 |
5 | MK 886 | authKW | 157873 | 2% | 21% | 13 |
6 | CYSLT2R | authKW | 151974 | 1% | 67% | 4 |
7 | 5 LIPOXYGENASE | authKW | 150092 | 8% | 6% | 46 |
8 | 3D COMPOUND TESTING | authKW | 113983 | 0% | 100% | 2 |
9 | 5 OXOETE | authKW | 113983 | 0% | 100% | 2 |
10 | CYSTEINYLLT1R | authKW | 113983 | 0% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 2955 | 39% | 0% | 213 |
2 | Cell Biology | 818 | 21% | 0% | 116 |
3 | Medicine, Research & Experimental | 504 | 12% | 0% | 68 |
4 | Biochemistry & Molecular Biology | 482 | 27% | 0% | 151 |
5 | Biophysics | 103 | 6% | 0% | 33 |
6 | Pharmacology & Pharmacy | 76 | 9% | 0% | 52 |
7 | Endocrinology & Metabolism | 65 | 5% | 0% | 30 |
8 | Gastroenterology & Hepatology | 33 | 3% | 0% | 17 |
9 | Biology | 18 | 2% | 0% | 13 |
10 | Pathology | 15 | 2% | 0% | 12 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOMIDE S | 170974 | 1% | 100% | 3 |
2 | GASTROINTESTINAL ONCOL S | 113983 | 0% | 100% | 2 |
3 | CELL EXPT PATHOL | 102576 | 1% | 30% | 6 |
4 | CLIN PHARM DIAGNOST | 85060 | 3% | 8% | 18 |
5 | LUMINAL GASTROENTEROL | 75987 | 0% | 67% | 2 |
6 | ALLGEMEINCHIRURG VISCERALCHIRURG | 56991 | 0% | 100% | 1 |
7 | ANIM PHYSIOL GEN ZOOL | 56991 | 0% | 100% | 1 |
8 | AUSTRIAN BREAST COLORECTAL CANC STUDY GRP ABCSG | 56991 | 0% | 100% | 1 |
9 | BIMOL MED PHARMACOL | 56991 | 0% | 100% | 1 |
10 | BIOCHEM BIONFORMAT | 56991 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 5203 | 3% | 1% | 17 |
2 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 2587 | 5% | 0% | 28 |
3 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 1457 | 1% | 0% | 7 |
4 | CANCER LETTERS | 881 | 3% | 0% | 14 |
5 | EXPERIMENTAL CELL RESEARCH | 844 | 3% | 0% | 14 |
6 | INTERNATIONAL JOURNAL OF CANCER | 778 | 3% | 0% | 17 |
7 | CANCER PREVENTION RESEARCH | 711 | 1% | 0% | 4 |
8 | VETERINARY AND COMPARATIVE ONCOLOGY | 488 | 0% | 0% | 2 |
9 | CARCINOGENESIS | 471 | 2% | 0% | 10 |
10 | FASEB JOURNAL | 455 | 2% | 0% | 9 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 12S HETE | 486311 | 3% | 53% | 16 | Search 12S+HETE | Search 12S+HETE |
2 | LY293111 | 279253 | 1% | 70% | 7 | Search LY293111 | Search LY293111 |
3 | 12 LIPOXYGENASE | 208259 | 5% | 15% | 25 | Search 12+LIPOXYGENASE | Search 12+LIPOXYGENASE |
4 | MK 886 | 157873 | 2% | 21% | 13 | Search MK+886 | Search MK+886 |
5 | CYSLT2R | 151974 | 1% | 67% | 4 | Search CYSLT2R | Search CYSLT2R |
6 | 5 LIPOXYGENASE | 150092 | 8% | 6% | 46 | Search 5+LIPOXYGENASE | Search 5+LIPOXYGENASE |
7 | 3D COMPOUND TESTING | 113983 | 0% | 100% | 2 | Search 3D+COMPOUND+TESTING | Search 3D+COMPOUND+TESTING |
8 | 5 OXOETE | 113983 | 0% | 100% | 2 | Search 5+OXOETE | Search 5+OXOETE |
9 | CYSTEINYLLT1R | 113983 | 0% | 100% | 2 | Search CYSTEINYLLT1R | Search CYSTEINYLLT1R |
10 | CYSTEINYLLT1R ANTAGONIST | 113983 | 0% | 100% | 2 | Search CYSTEINYLLT1R+ANTAGONIST | Search CYSTEINYLLT1R+ANTAGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |